Cargando…
Survivin and XIAP – two potential biological targets in follicular thyroid carcinoma
Follicular thyroid carcinoma’s (FTC) overall good prognosis deteriorates if the tumour fails to retain radioactive iodine. Therefore, new druggable targets are in high demand for this subset of patients. Here, we investigated the prognostic and biological role of survivin and XIAP in FTC. Survivin a...
Autores principales: | Werner, Thomas A., Dizdar, Levent, Nolten, Inga, Riemer, Jasmin C., Mersch, Sabrina, Schütte, Sina C., Driemel, Christiane, Verde, Pablo E., Raba, Katharina, Topp, Stefan A., Schott, Matthias, Knoefel, Wolfram T., Krieg, Andreas |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5595817/ https://www.ncbi.nlm.nih.gov/pubmed/28900184 http://dx.doi.org/10.1038/s41598-017-11426-3 |
Ejemplares similares
-
Preclinical assesement of survivin and XIAP as prognostic biomarkers and therapeutic targets in gastroenteropancreatic neuroendocrine neoplasia
por: Dizdar, Levent, et al.
Publicado: (2016) -
Survivin and XIAP: two valuable biomarkers in medullary thyroid carcinoma
por: Werner, Thomas A, et al.
Publicado: (2016) -
CXCR4/CXCR7/CXCL12-Axis in Follicular Thyroid Carcinoma
por: Werner, Thomas Artur, et al.
Publicado: (2018) -
CXCR4/CXCR7/CXCL12 axis promotes an invasive phenotype in medullary thyroid carcinoma
por: Werner, Thomas A, et al.
Publicado: (2017) -
Targeting abundant survivin expression in liposarcoma: subtype dependent therapy responses to YM155 treatment
por: Vay, Christian, et al.
Publicado: (2021)